SCHEMBL6558940

SCHEMBL6558940

O=c1c2ccc(Cl)cc2sc2ccc(Br)cc12

nearest known ligand 0.61

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
KDM4E B2RXH2 3/20 0.61
MIF P14174 2/20 0.46
BCKDK O14874 1/20 0.41
MCL1 Q07820 1/20 0.41
RXFP1 Q9HBX9 1/20 0.41
NPC1 O15118 3/20 0.39
MAPT P10636 3/20 0.39
RAB9A P51151 3/20 0.39
ALDH1A1 P00352 2/20 0.39
TDP1 Q9NUW8 1/20 0.39
L3MBTL1 Q9Y468 1/20 0.39
EPM2A O95278 1/20 0.38
PTPN2 P17706 1/20 0.38
PTPN1 P18031 1/20 0.38
PTPN22 Q9Y2R2 1/20 0.38
MGAM O43451 1/20 0.37
GAA P10253 1/20 0.37
SI P14410 1/20 0.37
MGAM2 Q2M2H8 1/20 0.37
CMA1 P23946 1/20 0.37

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL18261966 0.88 KDM4E (0.47) KDM4EMIFNPC1MAPTRAB9A
SCHEMBL30593470 0.88 KDM4E (0.47) KDM4EMIFNPC1MAPTRAB9A
SCHEMBL15989734 0.86 MIF (0.43) KDM4EMIFBCKDKMCL1RXFP1
SCHEMBL28529352 0.84 KDM4E (0.46) KDM4EMIFNPC1MAPTRAB9A
SCHEMBL29466898 0.84 KDM4E (0.48) KDM4EMIFNPC1MAPTRAB9A
SCHEMBL5019781 0.84 KDM4E (0.48) KDM4EMIFNPC1MAPTRAB9A
SCHEMBL13135167 0.81 KDM4E (0.54) KDM4EMIFNPC1MAPTRAB9A
SCHEMBL30406558 0.81 MIF (0.46) KDM4EMIFBCKDKMCL1RXFP1
SCHEMBL4919520 0.81 MIF (0.46) KDM4EMIFBCKDKMCL1RXFP1
SCHEMBL29450780 0.81 KDM4E (0.50) KDM4EMIFALDH1A1L3MBTL1EPM2A

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 16 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1294687-A2 1,2,4-TRISUBSTITUTED BENZENES AS INHIBITORS OF 15-LIPOXYGENASE WARNER-LAMBERT COMPANY (US) 2003-03-26 EP claimed
WO-2001096298-A2 1,2,4-TRISUBSTITUTED BENZENES AS INHIBITORS OF 15-LIPOXYGENASE WARNER-LAMBERT COMPANY (US) 2001-12-20 WO claimed
EP-1197491-B1 Thioxanthenone antitumor agents SANOFI AVENTIS (FR) 2004-12-29 EP disclosed
CN-1178651-C Lyophilized thioxanthenone anti-tumor angents ʥŵ��-�ϳ�ʵ����(����)���޹�˾ 2004-12-08 CN disclosed
EP-0917458-B1 LYOPHILIZED THIOXANTHENONE ANTIMUMOR AGENTS SANOFI SYNTHELABO INC (US) 2003-04-02 EP disclosed
EP-0882723-B1 Thioxanthenone antitumor agents SANOFI SYNTHELABO (FR) 2002-07-31 EP disclosed
EP-1197491-A1 Thioxanthenone antitumor agents SANOFI-SYNTHELABO (FR) 2002-04-17 EP disclosed
EP-0619315-B1 Thioxanthenone antitumor agents SANOFI SA (FR) 1999-06-09 EP disclosed
EP-0917458-A1 LYOPHILIZED THIOXANTHENONE ANTIMUMOR AGENTS SANOFI (FR) 1999-05-26 EP disclosed
EP-0882723-A1 Thioxanthenone antitumor agents SANOFI (FR) 1998-12-09 EP disclosed
CN-1201387-A Lyophilized thioxanthone antitumor agents SANOFI MEDICINES CO (FR) 1998-12-09 CN disclosed
US-5665760-A Lyophilized thioxanthenone antitumor agents SANOFI WINTHROP, INC. (US) 1997-09-09 US disclosed
WO-1997010809-A1 LYOPHILIZED THIOXANTHENONE ANTIMUMOR AGENTS SANOFI (FR) 1997-03-27 WO disclosed
US-5380749-A Thioxanthenone antitumor agents STERLING WINTHROP INC. (US) 1995-01-10 US disclosed
EP-0619315-A1 Thioxanthenone antitumor agents STERLING WINTHROP INC. (US) 1994-10-12 EP disclosed
US-5346917-A For mammals STERLING WINTHROP INC. (US) 1994-09-13 US disclosed